Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-12

Clinical Trial Update: A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy [Phase 4]

View source ↗

Summary

Phase 4 double-blind trial comparing two intravenous doses of esomeprazole after successful endoscopic therapy for upper gastrointestinal bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole (Esomeprazole)

Snippet

Sponsor: Taipei Medical University | Conditions: Upper Gastrointestinal Bleeding | Phase 4 | Status: UNKNOWN